SETDB1 and cancer: Moreover, SETDB1 was also found to repress the expression of radiation-induced ERVs, and SETDB1 deletion potently enhanced ERV expression and increased type I interferons, promoting antitumour immunity and sensitizing cancer radiotherapy (Pan et al., 2022).